Mass dose effects and in vivo affinity in brain PET receptor studies - a study of cerebral 5-HT4 receptor binding with [11C]SB207145

被引:44
作者
Madsen, Karine [1 ]
Marner, Lisbeth [1 ]
Haahr, Mette [1 ]
Gillings, Nic [2 ,3 ]
Knudsen, Gitte M. [1 ]
机构
[1] Rigshosp, Neurobiol Res Unit, Ctr Neurosci, DK-2100 Copenhagen, Denmark
[2] Rigshosp, PET, DK-2100 Copenhagen, Denmark
[3] Rigshosp, Cyclotron Unit, DK-2100 Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
PET; Injected mass; Mass dose; Occupancy; K-D; Human; POSITRON-EMISSION-TOMOGRAPHY; DRUG DEVELOPMENT; HUMANS; QUANTIFICATION; RADIOLIGANDS; OCCUPANCY; AGONISTS; DENSITY; LIGAND; IMAGES;
D O I
10.1016/j.nucmedbio.2011.04.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Attention to tracer dose principles is crucial in positron emission tomography (PET), and deviations can induce serious errors. In this study, we devise a method for determining receptor occupancy of the mass dose of the radioligand itself and the in vivo affinity. Methods: The approach was used for [C-11]SB207145, a new PET radioligand for imaging the cerebral 5-HT4 receptors in humans. Test-retest PET studies with varying specific activities of [C-11]SB207145 were conducted in seven healthy subjects, and the output parameter regional BPND was modeled. Individual occupancy plots were first computed to estimate the mass dose that saturates 50% of receptors (ID50), and subsequently, the maximal mass dose that can be injected (arbitrarily set at an occupancy <5%) was calculated. Scatchard plots were computed to estimate the in vivo K-D. Results: Increasing the mass dose resulted in a decrease in BPND, whilst the relative cerebellar uptake was unchanged. The ID50 was 85.4 +/- 30.2 mu g, and the upper mass dose limit was 4.5 +/- 1.6 mu g, which does not require ultrahigh specific activity. The estimated in vivo K-D was 2.8 nM (range 1.0-4.8), without any regional differences. Conclusion: The presented method for estimating the upper mass dose limit is suggested as part of validation of PET radioligands. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1085 / 1091
页数:7
相关论文
共 27 条
  • [1] Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET
    Ashworth, Sharon
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Plisson, Christophe
    Wilson, Alan A.
    Comley, Robert A.
    Lai, Robert Y. K.
    Gee, Antony D.
    Laruelle, Marc
    Cunningham, Vincent J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) : 1021 - 1029
  • [2] 5-HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice
    Cachard-Chastel, M.
    Lezoualc'h, F.
    Dewachter, I.
    Delomenie, C.
    Croes, S.
    Devijver, H.
    Langlois, M.
    Van Leuven, F.
    Sicsic, S.
    Gardier, A. M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (07) : 883 - 892
  • [3] Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival
    Cho, Seongeun
    Hu, Yun
    [J]. EXPERIMENTAL NEUROLOGY, 2007, 203 (01) : 274 - 278
  • [4] Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited
    Cunningham, Vincent J.
    Rabiner, Eugenii A.
    Slifstein, Mark
    Laruelle, Marc
    Gunn, Roger N.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (01) : 46 - 50
  • [5] Quantification in positron emission tomography for research in pharmacology and drug development
    Cunningham, VJ
    Gunn, RN
    Matthews, JC
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (07) : 643 - 646
  • [6] Derogatis L. R., 1994, Symptom Checklist-90-R: Administration, scoring and procedures manual, V3rd ed.
  • [7] VARIABILITY IN D-2-DOPAMINE RECEPTOR DENSITY AND AFFINITY - A PET STUDY WITH [C-11] RACLOPRIDE IN MAN
    FARDE, L
    HALL, H
    PAULI, S
    HALLDIN, C
    [J]. SYNAPSE, 1995, 20 (03) : 200 - 208
  • [8] A restricted access material for rapid analysis of [11C]-labeled radiopharmaceuticals and their metabolites in plasma
    Gillings, Nic
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (08) : 961 - 965
  • [9] Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
    Howes, O. D.
    Egerton, A.
    Allan, V.
    McGuire, P.
    Stokes, P.
    Kapur, S.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (22) : 2550 - 2559
  • [10] Consensus nomenclature for in vivo imaging of reversibly binding radioligands
    Innis, Robert B.
    Cunningham, Vincent J.
    Delforge, Jacques
    Fujita, Masahiro
    Giedde, Albert
    Gunn, Roger N.
    Holden, James
    Houle, Sylvain
    Huang, Sung-Cheng
    Ichise, Masanori
    Lida, Hidehiro
    Ito, Hiroshi
    Kimura, Yuichi
    Koeppe, Robert A.
    Knudsen, Gitte M.
    Knuuti, Juhani
    Lammertsma, Adriaan A.
    Laruelle, Marc
    Logan, Jean
    Maguire, Ralph Paul
    Mintun, Mark A.
    Morris'o, Evan D.
    Parsey, Ramin
    Price, Julie C.
    Slifstein, Mark
    Sossi, Vesna
    Suhara, Tetsuya
    Votaw, John R.
    Wong, Dean F.
    Carson, Richard E.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (09) : 1533 - 1539